Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
Fibplant
Fibplant Overview
Fibplant is developing a genetically engineered Fibrinogen, intended to be uses as a biological glue for an existing pharma drug market.
The company's advanced active compositions are based on therapeutic proteins produced in transgenic plants, and made for Surgery and Emergency medicine.
Cumulative Funding Raised Over Time ($)
Employees Over Time
Fibplant Climate Tech relevance
The existing Volumatic production of this drug today requires shipment of tons of liquids / month (Human Plasma) across the world to manufacturing facilities.
These periodic cycles within the production pipeline leave a significant carbon footprint that will be completely eliminated with Fibplants revolutionary manufacturing process that are expected to replace them.